Cargando…
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606736/ https://www.ncbi.nlm.nih.gov/pubmed/36283746 http://dx.doi.org/10.1136/lupus-2022-000755 |
_version_ | 1784818363532312576 |
---|---|
author | Cardwell, Francesca S Elliott, Susan J Chin, Ricky St Pierre, Yvan Choi, May Y Urowitz, Murray B Ruiz-Irastorza, Guillermo Bernatsky, Sasha Wallace, Daniel J Petri, Michelle A Manzi, Susan Bae, Sang-Cheol Shin, Jung-Min Mak, Anselm Cho, Jiacai Peschken, Christine A Ramsey-Goldman, Rosalind Fortin, Paul R Hanly, John G Pons-Estel, Bernardo A Nieto, Romina Askanase, Anca D Romero-Diaz, Juanita Mosca, Marta Bruce, Ian N Rowbottom, Leigha Mielczarek, Leanne Tse, Karin Marion, Ashley Cáhiz-González, Juan Carlos Cattoni, Teresa G Cornet, Alain Clarke, Ann Elaine |
author_facet | Cardwell, Francesca S Elliott, Susan J Chin, Ricky St Pierre, Yvan Choi, May Y Urowitz, Murray B Ruiz-Irastorza, Guillermo Bernatsky, Sasha Wallace, Daniel J Petri, Michelle A Manzi, Susan Bae, Sang-Cheol Shin, Jung-Min Mak, Anselm Cho, Jiacai Peschken, Christine A Ramsey-Goldman, Rosalind Fortin, Paul R Hanly, John G Pons-Estel, Bernardo A Nieto, Romina Askanase, Anca D Romero-Diaz, Juanita Mosca, Marta Bruce, Ian N Rowbottom, Leigha Mielczarek, Leanne Tse, Karin Marion, Ashley Cáhiz-González, Juan Carlos Cattoni, Teresa G Cornet, Alain Clarke, Ann Elaine |
author_sort | Cardwell, Francesca S |
collection | PubMed |
description | OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources. RESULTS: Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference −8.3%, 95% CI −10.2% to −6.5%; family physicians: 57.1% pre vs 50.0% post, difference −7.1%, 95% CI −9.2% to −5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted. CONCLUSIONS: Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation. |
format | Online Article Text |
id | pubmed-9606736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96067362022-10-27 Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic Cardwell, Francesca S Elliott, Susan J Chin, Ricky St Pierre, Yvan Choi, May Y Urowitz, Murray B Ruiz-Irastorza, Guillermo Bernatsky, Sasha Wallace, Daniel J Petri, Michelle A Manzi, Susan Bae, Sang-Cheol Shin, Jung-Min Mak, Anselm Cho, Jiacai Peschken, Christine A Ramsey-Goldman, Rosalind Fortin, Paul R Hanly, John G Pons-Estel, Bernardo A Nieto, Romina Askanase, Anca D Romero-Diaz, Juanita Mosca, Marta Bruce, Ian N Rowbottom, Leigha Mielczarek, Leanne Tse, Karin Marion, Ashley Cáhiz-González, Juan Carlos Cattoni, Teresa G Cornet, Alain Clarke, Ann Elaine Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources. RESULTS: Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference −8.3%, 95% CI −10.2% to −6.5%; family physicians: 57.1% pre vs 50.0% post, difference −7.1%, 95% CI −9.2% to −5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted. CONCLUSIONS: Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation. BMJ Publishing Group 2022-10-25 /pmc/articles/PMC9606736/ /pubmed/36283746 http://dx.doi.org/10.1136/lupus-2022-000755 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology and Outcomes Cardwell, Francesca S Elliott, Susan J Chin, Ricky St Pierre, Yvan Choi, May Y Urowitz, Murray B Ruiz-Irastorza, Guillermo Bernatsky, Sasha Wallace, Daniel J Petri, Michelle A Manzi, Susan Bae, Sang-Cheol Shin, Jung-Min Mak, Anselm Cho, Jiacai Peschken, Christine A Ramsey-Goldman, Rosalind Fortin, Paul R Hanly, John G Pons-Estel, Bernardo A Nieto, Romina Askanase, Anca D Romero-Diaz, Juanita Mosca, Marta Bruce, Ian N Rowbottom, Leigha Mielczarek, Leanne Tse, Karin Marion, Ashley Cáhiz-González, Juan Carlos Cattoni, Teresa G Cornet, Alain Clarke, Ann Elaine Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title_full | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title_fullStr | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title_full_unstemmed | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title_short | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
title_sort | health information use by patients with systemic lupus erythematosus (sle) pre and during the covid-19 pandemic |
topic | Epidemiology and Outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606736/ https://www.ncbi.nlm.nih.gov/pubmed/36283746 http://dx.doi.org/10.1136/lupus-2022-000755 |
work_keys_str_mv | AT cardwellfrancescas healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT elliottsusanj healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT chinricky healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT stpierreyvan healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT choimayy healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT urowitzmurrayb healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT ruizirastorzaguillermo healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT bernatskysasha healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT wallacedanielj healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT petrimichellea healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT manzisusan healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT baesangcheol healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT shinjungmin healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT makanselm healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT chojiacai healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT peschkenchristinea healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT ramseygoldmanrosalind healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT fortinpaulr healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT hanlyjohng healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT ponsestelbernardoa healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT nietoromina healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT askanaseancad healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT romerodiazjuanita healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT moscamarta healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT bruceiann healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT rowbottomleigha healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT mielczarekleanne healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT tsekarin healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT marionashley healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT cahizgonzalezjuancarlos healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT cattoniteresag healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT cornetalain healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic AT clarkeannelaine healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic |